Janusz Prokopczuk - Publications

Extended dual antithrombotic therapy in patients with chronic coronary syndrome - which agent should be added to aspirin?

Journal: Cardiology journal

Published: February 13, 2025

Comparison of reorganized versus unaltered cardiology departments during the COVID-19 era: A subanalysis of the COV-HF-SIRIO 6 study.

Journal: Cardiology journal

Published: September 07, 2022

Impact of COVID-19 pandemic on acute heart failure admissions and mortality: a multicentre study (COV-HF-SIRIO 6 study).

Journal: ESC heart failure

Published: June 28, 2021

Comparison of Investigator-Reported and Clinical Event Committee-Adjudicated Outcome Events in GLASSY.

Journal: Circulation. Cardiovascular quality and outcomes

Published: February 04, 2021

PRECISE-DAPT score for bleeding risk prediction in patients on dual or single antiplatelet regimens: insights from the GLOBAL LEADERS and GLASSY.

Journal: European heart journal. Cardiovascular pharmacotherapy

Published: June 16, 2020

Ticagrelor monotherapy beyond one month after PCI in ACS or stable CAD in elderly patients: a pre-specified analysis of the GLOBAL LEADERS trial.

Journal: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

Published: December 18, 2019

Ticagrelor Alone Versus Dual Antiplatelet Therapy From 1 Month After Drug-Eluting Coronary Stenting.

Journal: Journal of the American College of Cardiology

Published: May 02, 2019

Rationale and design of a prospective substudy of clinical endpoint adjudication processes within an investigator-reported randomised controlled trial in patients with coronary artery disease: the GLOBAL LEADERS Adjudication Sub-StudY (GLASSY).

Journal: BMJ open

Published: March 11, 2019

Predictive ability of ACEF and ACEF II score in patients undergoing percutaneous coronary intervention in the GLOBAL LEADERS study.

Journal: International journal of cardiology

Published: October 31, 2018

Safety and efficacy of a sirolimus-eluting coronary stent with ultra-thin strut for treatment of atherosclerotic lesions (TALENT): a prospective multicentre randomised controlled trial.

Journal: Lancet (London, England)

Published: September 03, 2018